Donald W. DeGolyer - 12 Nov 2024 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
Director
Signature
/s/ Richard S. Lindahl, Attorney-in-fact
Issuer symbol
EBS
Transactions as of
12 Nov 2024
Net transactions value
-$272,750
Form type
4
Filing time
14 Nov 2024, 16:18:57 UTC
Previous filing
28 May 2024
Next filing
02 May 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Sale $272,750 -25,000 -18% $10.91 111,100 12 Nov 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On November 12, 2024, Mr. DeGolyer sold an aggregate of 25,000 shares of Emergent BioSolutions Inc. common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $10.83 - $11.05. The Company maintains a record of the transactions and copies will be provided upon request.